First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2
First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2 GlobeNewswire July 24, 2025 Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches […]